Literature DB >> 3529783

Insulin release and pancreatic insulin is reduced in young prediabetic BB rats.

A Svenningsen, T Dyrberg, H Markholst, C Binder, A Lernmark.   

Abstract

The pancreases of approximately 50 days old diabetes-prone BB/Hagedorn (BB/H) and of the genetically closely related, but non-diabetic BB w-subline (control BB) rats were perfused to determine the capacity of D-glucose to release insulin before the expected development of diabetes. The BB/H rats were from a colony with 82-84% incidence of insulin-dependent diabetes mellitus (IDDM) by 140 days of age. The total amount of insulin released from the BB/H rat pancreas during stimulation with 20 mmol/1 mmol/ D-glucose was reduced by nearly 50% (P less than 0.01). The initial peak of insulin release was similar between the two groups of animals, whereas the amount of insulin released during the second peak accounted for the diminished release (P less than 0.01). The extractable pancreatic insulin was 30% (P less than 0.05) less in the BB/H rats. Total insulin release expressed relative to the pancreatic insulin content, was therefore not different between the two groups. It is concluded that about 20-40 days before the mean age of clinical onset of IDDM in BB/H rats, the capacity to release insulin in response to D-glucose is reduced along with a diminished pancreatic insulin content. This abnormality seems to be preceded only by islet cell surface antibodies but not by insulitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3529783     DOI: 10.1530/acta.0.1120367

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  7 in total

1.  Gene probes to detect cross-culture contamination in hormone producing cell lines.

Authors:  I Matsuba; A Lernmark; O Madsen; B Michelsen; J H Nielsen; J Scholler; H Vissing; B Welinder; N Tommerup; M Mikkelsen
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

2.  Functional and morphological effects of interleukin-1 beta on the perfused rat pancreas.

Authors:  L D Wogensen; V Kolb-Bachofen; P Christensen; C A Dinarello; T Mandrup-Poulsen; S Martin; J Nerup
Journal:  Diabetologia       Date:  1990-01       Impact factor: 10.122

3.  Inhibition of diabetes in BB rats by virus infection.

Authors:  T Dyrberg; P L Schwimmbeck; M B Oldstone
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.

Authors:  S Baekkeskov; M Landin; J K Kristensen; S Srikanta; G J Bruining; T Mandrup-Poulsen; C de Beaufort; J S Soeldner; G Eisenbarth; F Lindgren
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

5.  Repetitive in vivo treatment with human recombinant interleukin-1 beta modifies beta-cell function in normal rats.

Authors:  L D Wogensen; J Reimers; J Nerup; V Kolb-Bachofen; K D Kröncke; T Almdal; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

6.  Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.

Authors:  Anya Medina; Saba Parween; Sara Ullsten; Neelanjan Vishnu; Yuk Ting Siu; My Quach; Hedvig Bennet; Alexander Balhuizen; Lina Åkesson; Nils Wierup; Per Ola Carlsson; Ulf Ahlgren; Åke Lernmark; Malin Fex
Journal:  Diabetologia       Date:  2017-12-06       Impact factor: 10.122

7.  Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence.

Authors:  M B Oldstone
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.